KRAS and neoplasm: Furthermore, TRACERx researchers explored the relationship between cancer treatment and anti-tumour immune response.7 In mouse models and patient samples, they discovered B-cell proliferation in tumour-adjacent tertiary lymphoid structures (TLS) that were increased by immunotherapy and KRAS inhibition.